Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection

  • Read more about Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection

CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction

  • Read more about CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction

Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs

  • Read more about Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs

Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)

  • Read more about Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Lomecel-B (RECOVER)

Head and Neck cancERs International cOviD-19 collabOraTion

  • Read more about Head and Neck cancERs International cOviD-19 collabOraTion

Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC

  • Read more about Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC

Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)

  • Read more about Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)

Methylene Blue Treatment of COVID-19

  • Read more about Methylene Blue Treatment of COVID-19

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

  • Read more about Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection

  • Read more about A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 Infection

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 225
  • Page 226
  • Page 227
  • Page 228
  • Current page 229
  • Page 230
  • Page 231
  • Page 232
  • Page 233
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA